Announcement

Our User Community can enter the Library on Mondays and Thursdays from 8:30 am to 5:00 pm (12:30 pm to 1:00 pm closed for additional cleaning of user workstations).

All MSK Staff must register for their user workstation in advance at: https://mskcc.libcal.com/spaces.
Additional info: Reopening Guidelines & Procedures

The MSK User Community can access the majority of the Library's services and collections remotely. Visit our Virtual Library Services page to learn more.

Looking for information about COVID-19? Visit our post on the MSK Library Blog to browse vetted resources and sites.

 

News & Events
LibGuides
custom research guides

Evidence-Based Practice

Defining PICO & related info

NIH Public Access Policy

Info & guidance for complying

Nursing Resources

eJournals and Websites

See all


Today's Science Sparks
Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trial. Fig. 1. Durvalumab plus tremelimumab combination therapy with or without paclitaxel administration schedule.
Boileve A, Hilmi M, Gougis P, Cohen R, Rousseau B, Blanc JF, Ben Abdelghani M, Castanie H, Dahan L, Tougeron D, Metges JP, Tournigand C, Garcia-Larnicol ML, Vernerey D, Turpin A, Neuzillet C
Synapse
MSK's DISTINGUISHED AUTHORS
Recent Blog Posts
Today's Hours

Saturday, January 16, 2021

Library Staff Onsite:
Mon/Thurs, 8:30am-5:00pm

Closed: Tues, Wed, Fri

Nathan Cummings Center
Rockefeller Research Laboratories (RRL)
Building, SR-101

Virtual Library Services

Library Dashboard